You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Quality of Life Questionnaire 20-item Multiple Myeloma module

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

Not yet recruiting
  • Multiple Myeloma
  • Supportive Care (home-based physical activity)
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Quality of Life in Asymptomatic Monoclonal Gammopathies

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Plasma Cell Myeloma Trial in Buffalo (device, other, behavioral)

Active, not recruiting
  • Plasma Cell Myeloma
  • FitBit
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Sep 21, 2022

Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life

Not yet recruiting
  • Plasma Cell Myeloma
  • Daratumumab and Hyaluronidase-fihj
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Plasma Cell Myeloma Trial in Buffalo (Best Practice, Kefir, Quality-of-Life Assessment)

Completed
  • Plasma Cell Myeloma
  • Best Practice
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 15, 2021

Plasma Cell Myeloma Trial in Duarte (Best Practice, Exercise Intervention, Quality-of-Life Assessment)

Recruiting
  • Plasma Cell Myeloma
  • Best Practice
  • +3 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 3, 2022

Bone Pain, Metastatic Malignant Tumor in the Bone, Plasma Cell Myeloma Trial in United States (Quality-of-Life Assessment,

Recruiting
  • Bone Pain
  • +2 more
  • Quality-of-Life Assessment
  • +2 more
  • Duarte, California
  • +7 more
Feb 25, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Health Promotion and Education
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 24, 2023

Multiple Myeloma in West-Occitanie Region "Living WithMyeloma in

Recruiting
  • Multiple Myeloma
  • quality of life questionnaires (EORTC QLQ-C30 ; EORTC QLQMY20 ; EQ-5D-5L ; Cohen's stress scale)
  • Toulouse, West-Occitanie, France
    IUCT-Oncopole - Toulouse University Hospital
Mar 1, 2022

Lymphoma, Plasma Cell Myeloma Trial in Atlanta (Quality-of-Life Assessment, Questionnaire Administration, Spiritual Therapy)

Recruiting
  • Lymphoma
  • Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Apr 13, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 3, 2022

Monoclonal Gammopathy of Undetermined Significance Trial in Reykjavík (Clinical follow-up 1, Mental Health and Quality of Life

Active, not recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Clinical follow-up 1
  • +5 more
  • Reykjavík, Iceland
    University of Iceland
Feb 28, 2022

Elranatamab, Myeloma, Multiple Myeloma Trial in China (Elranatamab)

Recruiting
  • Elranatamab
  • +10 more
  • Fuzhou, Fujian, China
  • +18 more
Jan 18, 2023

Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)

Recruiting
  • Multiple Myeloma
  • Relapsed Hematologic Malignancy
  • Digital Health Coaching Program
  • Fitbit
  • Seattle, Washington
    University of Washington
Jul 13, 2023

Multiple Myeloma, Refractory Multiple Myeloma Trial in Houston (Digital Health Coaching Program, Fitbit)

Recruiting
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • Digital Health Coaching Program
  • Fitbit
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 17, 2022

After Whole Brain Radiation Therapy for Hematologic Malignancies

Recruiting
  • Central Nervous System Lymphoma
  • +5 more
  • Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 12, 2021

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

Revision of the EORTC QLQ-BN20 Questionnaire

Recruiting
  • Glioma
  • Brain Metastases, Adult
  • No intervention
  • Leiden, South-Holland, Netherlands
    Leiden University Medical Center
Dec 29, 2020

Plasma Cell Myeloma Trial in Worldwide (isatuximab SAR650984, Pomalidomide, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • isatuximab SAR650984
  • +3 more
  • Little Rock, Arkansas
  • +83 more
Aug 12, 2022

Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cells
  • +8 more
  • Freiburg, Baden-Württemberg, Germany
  • +31 more
Jan 5, 2023

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Daratumumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Yuma, Arizona
  • +150 more
Dec 9, 2022

Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +8 more
  • Birmingham, Alabama
  • +59 more
Dec 13, 2022

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in United States (REGN5459)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Indianapolis, Indiana
  • +6 more
Aug 16, 2022